Orally-Disintegrating Tablet Granule Coating Integrity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing orally-disintegrating solid preparations face issues with fine granule breakage during tabletting, leading to decreased masking of bitter tastes and acid resistance, which affects the controlled release of pharmaceutically active ingredients.

Innovation Solution

Coating fine granules with a polymer layer that provides a casting film with an elongation at break of 100-700%, which reduces breakage and maintains the integrity of the coating layer during tablet production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If fine granules are used in orally-disintegrating tablets, then disintegration and controlled release are improved, but breakage of fine granules during tabletting occurs

Engineering Contradiction:
Improvecontrolled releaseVSAvoidgranule integrity
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The fine granules are pre-coated with a polymer layer before tabletting to strengthen their structure. This preliminary coating action prevents breakage during the subsequent tabletting process while maintaining the controlled release properties of the fine granules.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A composite coating layer is applied to the fine granules, combining polymer materials with specific properties (elongation at break of 100-700%) to create a strengthened granule structure that resists breakage during tabletting while preserving controlled release functionality.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If coating layer is applied to fine granules, then masking effect and acid resistance are improved, but breakage during tabletting decreases the coating integrity

Engineering Contradiction:
Improveacid resistanceVSAvoidcoating layer integrity
Core Design Contradiction:
Object-affected harmful factorsVSStability of the object's composition

Solution Approach 1:

The polymer coating is applied to the fine granules before tabletting to establish protective acid-resistant properties. This preliminary coating ensures that the coating layer remains intact during tabletting and maintains its acid resistance throughout the product's shelf life and administration.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The polymer coating is specifically designed with controlled elongation at break (100-700%) to optimize both coating integrity during tabletting and functional properties like acid resistance. This parameter control ensures the coating remains stable under mechanical stress during manufacturing while maintaining its protective function.

Inventive Principle:
Principle #35Parameter changes

3Strength

If polymer coating with high elongation at break is applied, then breakage is suppressed, but coating formulation complexity increases

Engineering Contradiction:
Improvegranule strengthVSAvoidcoating formulation
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

Instead of using complex multi-layer coatings or multiple materials, the invention achieves granule strength enhancement by carefully controlling the elongation at break parameter of a single polymer coating layer to fall within 100-700%. This parameter optimization simplifies the coating formulation while effectively preventing breakage during tabletting.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9241910B2Orally-disintegrating solid preparation
Publication Date: 2016.01.26 TAKEDA PHARMA CO LTD
  • US9241910B2 patent drawing

AI summary

The present invention provides an orally-disintegrating solid preparation such as a tablet produced by tabletting fine granules showing controlled release of a pharmaceutically active ingredient and an additive, and the like, and the orally-disintegrating solid preparation containing fine granules coated with a coating layer containing a polymer affording a casting film having an elongation at break of about 100-about 700%. With the preparation, breakage of fine granules during tabletting can be suppressed in the production of an orally-disintegrating solid preparation containing fine granules showing controlled release of a pharmaceutically active ingredient.